Literature DB >> 12405384

Neural and marrow-derived stromal cell sphere transplantation in a rat model of traumatic brain injury.

Dunyue Lu1, Ya Li, Asim Mahmood, Lei Wang, Tahir Rafiq, Michael Chopp.   

Abstract

OBJECT: This study was designed to investigate the effect of treatment with a novel composite material consisting of embryonic neurospheres and bone marrow-derived stromal cell spheres (NMSCSs) in a rat model of traumatic brain injury (TBI).
METHODS: The NMSCS composite was injected into the TBI contusion site 24 hours after injury, and all rats were killed on Day 14 after the transplantation. The Rotarod test and the neurological severity score were used to evaluate neurological function. The transplanted NMSCS was analyzed in recipient rat brains by using histological staining and laser scanning confocal microscopy. The lesion volumes in the brains were also calculated using computer image analysis.
CONCLUSIONS: Rats that received NMSCS transplants had reduced lesion volume and showed improved motor and neurological function when compared with control groups 14 days after the treatment. These results suggest that transplantation of this novel biological material (NMSCS) may be useful in the treatment of TBI.

Entities:  

Mesh:

Year:  2002        PMID: 12405384     DOI: 10.3171/jns.2002.97.4.0935

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  14 in total

1.  Treatment of traumatic brain injury in mice with bone marrow stromal cell-impregnated collagen scaffolds.

Authors:  Changsheng Qu; Ye Xiong; Asim Mahmood; David L Kaplan; Anton Goussev; Ruizhuo Ning; Michael Chopp
Journal:  J Neurosurg       Date:  2009-10       Impact factor: 5.115

2.  Neurotrophic actions of bone marrow stromal cells on primary culture of dorsal root ganglion tissues and neurons.

Authors:  Yun Gu; Jie Wang; Fei Ding; Nan Hu; Yaxian Wang; Xiaosong Gu
Journal:  J Mol Neurosci       Date:  2009-11-06       Impact factor: 3.444

Review 3.  Cell-based therapy for traumatic brain injury.

Authors:  S Gennai; A Monsel; Q Hao; J Liu; V Gudapati; E L Barbier; J W Lee
Journal:  Br J Anaesth       Date:  2015-08       Impact factor: 9.166

Review 4.  Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.

Authors:  Yossef S Levy; Merav Stroomza; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

5.  Protective effects of BDNF overexpression bone marrow stromal cell transplantation in rat models of traumatic brain injury.

Authors:  Zhitao Wang; Weifeng Yao; Quanjun Deng; Xiaohui Zhang; Jianning Zhang
Journal:  J Mol Neurosci       Date:  2012-11-11       Impact factor: 3.444

6.  Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats.

Authors:  Asim Mahmood; Dunyue Lu; Changsheng Qu; Anton Goussev; Michael Chopp
Journal:  Neurosurgery       Date:  2005-11       Impact factor: 4.654

7.  Treatment of TBI with collagen scaffolds and human marrow stromal cells increases the expression of tissue plasminogen activator.

Authors:  Asim Mahmood; Changsheng Qu; Riuzuo Ning; Hongtao Wu; Anton Goussev; Ye Xiong; Susan Irtenkauf; Yi Li; Michael Chopp
Journal:  J Neurotrauma       Date:  2011-05-16       Impact factor: 5.269

8.  Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cells.

Authors:  Yossef S Levy; Doron Merims; Hanna Panet; Yael Barhum; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 9.  Cell therapies for traumatic brain injury.

Authors:  Matthew T Harting; James E Baumgartner; Laura L Worth; Linda Ewing-Cobbs; Adrian P Gee; Mary-Clare Day; Charles S Cox
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

10.  Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres.

Authors:  Faten Zaibak; Paul Bello; Jennifer Kozlovski; Duncan Crombie; Haozhi Ang; Mirella Dottori; Robert Williamson
Journal:  BMC Biotechnol       Date:  2009-12-15       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.